Cybersecurity risk assessment services

Nova Leah is now offering a hands-on risk assessment solution. Our team of experts will assist in performing risk analyses, risk evaluations and security control identification in line with regulatory expectations. We work hand-in-hand with you, navigating you through this complex process.
  • Comprehensive review with industry experts.
  • Risk analysis, evaluation and security control.
  • Get your products to market quicker.
  • Maintain security assurances post-market.
  • Increase in-house efficiency.

-

Technology Ireland Awards | Ibec
Emerging Company of the Year -2019

Awards

iea-award-logow
High Potential Exporter Award
Export Industry Awards  Winner 2019

-

KTI Impact Awards 2019
Spin-out Company Award Winner 2019

Accelerate the risk assessment process

Our services solution is backed by SelectEvidence®, which allows manufacturers of connected medical devices to automate the process of conducting premarket and postmarket cybersecurity risk assessments for entire product portfolios.

SelectEvidence® breakdown:

    • Risk assessment platform.
    • sBoM ingestion.
    • Continuous vulnerability monitoring.
    • Automated MDF2 generation.
    • Risk analysis decision support.
    • Threat modelling.
    • FDA premarket and postmarket cybersecurity compliance.

Managed risk assessment services

Cybersecurity risk assessment packages

Bronze

One time assessment report

Our team of experts will assist in performing risk analyses, risk evaluations and security control identification in line with regulatory expectations. This is a short-term engagement, typically one-time assessment of one product. 

Silver

Risk assessment setup and handover

Our team take you through the initial cybersecurity risk assessment process before setting you up with a SelectEvidence® license. Package includes one-time risk assessment and ongoing monitoring via the SelectEvidence® platform. 

Gold 

Ongoing risk assessment support

Once initial risk assessment is carried out and your team is set up with SelectEvidence®, we remain on board as a dedicated partner.  This includes monthly consultations and ongoing support with your risk assessment activities.  

Leadership team

Anita Finnegan
CEO/Founder

Anita founded Nova Leah and is the Author and International Project Leader of IEC 80001-2-8 and IEC 80001-2-9. As an ...internationally recognized expert in Medical Device Cybersecurity she also has a strong background in software quality processes, engineering and quality engineering roles across multiple highly regulated domains. Anita's PhD research focused on medical device cybersecurity assurance cases.

Peter Finnegan
Co-Founder

Peter brings over 30 years’ experience in the global healthcare and pharmaceutical business to Nova Leah. Peters expertise ...culminated over 28 years of senior management leadership.

Fergal McCaffery
Co-founder / Head of Engineering

Fergal is internationally recognized for his contributions to medical device software engineering. His research team ...have led the development of 4 International Standards/Technical reports for medical device software. He was also the Leader for the development of IEC/TR 80002-3 for medical device software processes in collaboration with the ISO/IEC 62304 development team. Fergal is also Senior Lecturer in the Department of Computing and Mathematics, in Dundalk Institute of Technology (DkIT).